journal article·2025-06-12Open access

A Modular Biomimetic Preclinical Platform to Elucidate the Interaction Between Cancer Cells and the Bone Metastatic Niche

Claudia Cocchi, Massimiliano Dapporto, Ania Naila Guerrieri, Chiara Liverani, Marta Tavoni, Chiara Bellotti, Chiara Spadazzi, Anna Tampieri, Marco Gambarotti, Giacomo Miserocchi, Simone Sprio, Enrico Lucarelli, Michele Iafisco, Toni Ibrahim, Alessandro De Vita, Laura Mercatali

Abstract

Breast cancer (BC) frequently metastasizes to bone, leading to poor patient prognosis. The infiltration of cancer cells in bone impairs its homeostasis, triggering a pathological interaction between tumors and resident cells. Preclinical models able to mimic the bone microenvironment are needed to advance translational findings on BC mechanisms and treatments. We designed strontium-doped calcium phosphate cement to be employed for culturing cancer and bone cells and developed an in vitro bone metastasis model. The platform was established step by step, starting with the monoculture of cancer cells, mature osteoblasts (OBs) differentiated from mesenchymal stem cells, and mature osteoclasts (OCs) differentiated from Peripheral Blood Mononuclear Cells. The model was implemented with the co-culture of cancer cells with OBs or OCs, or the co-culture of OBs and OCs, allowing us to discriminate the interaction between the actors of the bone metastatic niche. The biomimetic material was further challenged with bone metastasis patient-derived material, showing good versatility and biocompatibility, suggesting its potential use as bone substitute. Overall, we developed a bone-mimicking model able to reproduce reciprocal interactions between cancer and bone cells in a biomimetic environment suitable for studying the biomolecular determinants of bone metastasis and, in the future, as a drug efficacy platform.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone health and treatments · Cancer Cells and Metastasis · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Preclinic and Osteoncology Unit, Bioscience Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Via P. Maroncelli 40, 47014 Meldola, Italy

Institute of Science, Technology and Sustainability for Ceramics (ISSMC), National Research Council (CNR), Via Granarolo 64, 48018 Faenza, Italy

Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies Unit, IRCCS Istituto Ortopedico Rizzoli, Via di Barbiano 1/10, 40136 Bologna, Italy

Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy

Funding

Ministero della Salute, Progetto Ricerca Finalizzata

References (65)

Show source-provided references
1. Breast cancer statistics 202410.3322/caac.21863 ↗
2. Sui, L., Wang, J., Jiang, W.G., Song, X., and Ye, L. (2024). Molecular mechanism of bone metastasis in breast cancer. Front. Oncol., 13.10.3389/fonc.2024.1401113 ↗
3. Breast cancer: Pathogenesis and treatments10.1038/s41392-024-02108-4 ↗
5. A multigenic program mediating breast cancer metastasis to bone10.1016/S1535-6108(03)00132-6 ↗
6. Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells10.1016/j.ccr.2010.12.022 ↗
7. Breast cancer cells interact with osteoblasts to support osteoclast formation10.1210/endo.140.10.7037 ↗
8. CXCL12 (SDF-1)/CXCR4 pathway in cancer10.1158/1078-0432.CCR-09-2329 ↗
9. Unravelling the complexity of metastasis—Molecular understanding and targeted therapies10.1038/nrc3125 ↗
10. Clinical features of metastatic bone disease and risk of skeletal morbidity10.1158/1078-0432.CCR-06-0931 ↗
11. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A randomised, double-blind study10.1016/S0140-6736(10)62344-6 ↗
12. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: A randomized, double-blind study10.1200/JCO.2010.29.7101 ↗
13. Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma10.1200/JCO.2010.31.3304 ↗
14. Del Conte, A., De Carlo, E., Bertoli, E., Stanzione, B., Revelant, A., Bertola, M., Spina, M., and Bearz, A. (2022). Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical Implications. Int. J. Mol. Sci., 23.10.3390/ijms23126832 ↗
15. Co-culture systems of osteoblasts and osteoclasts: Simulating In Vitro bone remodeling in regenerative approaches10.1016/j.actbio.2020.03.043 ↗
16. Synthetic scaffolds for musculoskeletal tissue engineering: Cellular responses to fiber parameters10.1038/s41536-019-0076-5 ↗
17. Pathi, S.P., Kowalczewski, C., Tadipatri, R., and Fischbach, C. (2010). A novel 3-D mineralized tumor model to study breast cancer bone metastasis. PLoS ONE, 5.10.1371/journal.pone.0008849 ↗
18. Engineered silk fibroin protein 3D matrices for in vitro tumor model10.1016/j.biomaterials.2010.11.052 ↗
19. A novel model of dormancy for bone metastatic breast cancer cells10.1158/0008-5472.CAN-13-0991 ↗
20. Microcalcifications in breast cancer: Novel insights into the molecular mechanism and functional consequence of mammary mineralisation10.1038/bjc.2011.583 ↗
21. Sohn, H.S., and Oh, J.K. (2019). Review of bone graft and bone substitutes with an emphasis on fracture surgeries. Biomater. Res., 23.10.1186/s40824-019-0157-y ↗
22. A broader strategy for osteoporosis interventions10.1038/s41574-020-0339-7 ↗
23. Fabrication and Biological Activity of 3D-Printed Polycaprolactone/Magnesium Porous Scaffolds for Critical Size Bone Defect Repair10.1021/acsbiomaterials.9b01911 ↗
24. Jeong, J., Kim, J.H., Shim, J.H., Hwang, N.S., and Heo, C.Y. (2019). Bioactive calcium phosphate materials and applications in bone regeneration. Biomater. Res., 23.10.1186/s40824-018-0149-3 ↗
25. Calcium phosphate cements: Optimization toward biodegradability10.1016/j.actbio.2020.10.013 ↗
26. Sprio, S., Dapporto, M., Montesi, M., Panseri, S., Lattanzi, W., Pola, E., Logroscino, G., and Tampieri, A. (2016). Novel Osteointegrative Sr-Substituted Apatitic Cements Enriched with Alginate. Materials, 9.10.3390/ma9090763 ↗
27. Montesi, M., Panseri, S., Dapporto, M., Tampieri, A., and Sprio, S. (2017). Sr-substituted bone cements direct mesenchymal stem cells, osteoblasts and osteoclasts fate. PLoS ONE, 12.10.1371/journal.pone.0172100 ↗
28. Use of radiation in biomaterials science10.1016/S0168-583X(02)00647-X ↗
29. Effectiveness of UV-C radiation in inactivation of microorganisms on materials with different surface structures
30. Tapia-Guerrero, Y.S., Del Prado-Audelo, M.L., Borbolla-Jiménez, F.V., Gomez, D.M.G., García-Aguirre, I., Colín-Castro, C.A., Morales-González, J.A., Leyva-Gómez, G., and Magaña, J.J. (2020). Effect of UV and Gamma Irradiation Sterilization Processes in the Properties of Different Polymeric Nanoparticles for Biomedical Applications. Materials, 13.10.3390/ma13051090 ↗
31. Mercatali, L., Spadazzi, C., Miserocchi, G., Liverani, C., De Vita, A., Bongiovanni, A., Recine, F., Amadori, D., and Ibrahim, T. (2016). The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts. Int. J. Mol. Sci., 17.10.3390/ijms17111827 ↗
32. Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events10.4161/cc.28401 ↗
33. The potential role of the extracellular matrix in the activity of trabectedin in UPS and L-sarcoma: Evidences from a patient-derived primary culture case series in tridimensional and zebrafish models10.1186/s13046-021-01963-1 ↗
34. Guerrieri, A.N., Bellotti, C., Penzo, M., Columbaro, M., Pannella, M., De Vita, A., Gambarotti, M., Mercatali, L., Laranga, R., and Dozza, B. (2023). A novel patient-derived immortalised cell line of myxofibrosarcoma: A tool for preclinical drugs testing and the generation of near-patient models. BMC Cancer, 23.10.1186/s12885-023-11658-9 ↗
35. Rapid and simple comparison of messenger RNA levels using real-time PCR10.1251/bpo114 ↗
36. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development10.1172/JCI3523 ↗
37. Extracellular matrix mechanobiology in cancer cell migration10.1016/j.actbio.2022.10.016 ↗
38. Engineering a Novel 3D Printed Vascularized Tissue Model for Investigating Breast Cancer Metastasis to Bone10.1002/adhm.201900924 ↗
39. Human breast cancer bone metastasis In Vitro and In Vivo: A novel 3D model system for studies of tumour cell-bone cell interactions10.1007/s10585-015-9737-y ↗
40. A microfluidic 3D In Vitro model for specificity of breast cancer metastasis to bone10.1016/j.biomaterials.2013.11.050 ↗
41. One size does not fit all: Developing a cell-specific niche for In Vitro study of cell behavior10.1016/j.matbio.2016.01.004 ↗
42. 3D Bioprinting for Tumor Metastasis Research10.1021/acsbiomaterials.3c00239 ↗
43. A 3D printed nano bone matrix forcharacterization of breast cancer cell and osteoblast interactions10.1088/0957-4484/27/31/315103 ↗
44. Glaser, D.E., Curtis, M.B., Sariano, P.A., Rollins, Z.A., Shergill, B.S., Anand, A., Deely, A.M., Shirure, V.S., Anderson, L., and Lowen, J.M. (2022). Organ-on-a-chip model of vascularized human bone marrow niches. Biomaterials, 280.10.1016/j.biomaterials.2021.121245 ↗
45. Potentiation of the antitumor effect of calcium phosphate cement containing anticancer drug and caffeine on rat osteosarcoma10.1007/s00776-011-0045-3 ↗
46. An injectable calcium phosphate cement for the local delivery of paclitaxel to bone10.1016/j.biomaterials.2011.04.010 ↗
47. The efficacy of methotrexate-impregnated hydroxyapatite composites on human mammary carcinoma cells10.1177/230949900701500113 ↗
48. The advantages of co-culture over mono cell culture in simulating in vivo environment10.1016/j.jsbmb.2011.12.004 ↗
49. Bi-directional modulation of cellular interactions in an In Vitro co-culture model of tendon-to-bone interface10.1111/cpr.12493 ↗
50. Dapporto, M., Tavoni, M., Restivo, E., Carella, F., Bruni, G., Mercatali, L., Visai, L., Tampieri, A., Iafisco, M., and Sprio, S. (2022). Strontium-doped apatitic bone cements with tunable antibacterial and antibiofilm ability. Front. Bioeng. Biotechnol., 10.10.3389/fbioe.2022.969641 ↗
51. Sheng, X., Li, C., Wang, Z., Xu, Y., Sun, Y., Zhang, W., Liu, H., and Wang, J. (2023). Advanced applications of strontium-containing biomaterials in bone tissue engineering. Mater. Today Bio, 20.10.1016/j.mtbio.2023.100636 ↗
52. Liverani, C., De Vita, A., Minardi, S., Kang, Y., Mercatali, L., Amadori, D., Bongiovanni, A., La Manna, F., Ibrahim, T., and Tasciotti, E. (2019). A biomimetic 3D model of hypoxia-driven cancer progression. Sci. Rep., 9.10.1038/s41598-019-48701-4 ↗
53. Bone-matrix mineralization dampens integrin-mediated mechanosignalling and metastatic progression in breast cancer10.1038/s41551-023-01077-3 ↗
54. Pylostomou, A., Demir, Ö., and Loca, D. (2023). Calcium phosphate bone cements as local drug delivery systems for bone cancer treatment. Biomater. Adv., 148.10.1016/j.bioadv.2023.213367 ↗
55. Dewhurst, R.M., Scalzone, A., Buckley, J., Mattu, C., Rankin, K.S., Gentile, P., and Ferreira, A.M. (2020). Development of Natural-Based Bone Cement for a Controlled Doxorubicin-Drug Release. Front. Bioeng. Biotechnol., 8.10.3389/fbioe.2020.00754 ↗
56. Modulation of Alendronate release from a calcium phosphate bone cement: An In Vitro osteoblast-osteoclast co-culture study10.1016/j.ijpharm.2018.11.023 ↗
57. Bone Endosteal Mimics Regulates Breast Cancer Development and Phenotype10.1021/acs.biomac.3c01217 ↗
58. Bassi, G., Panseri, S., Dozio, S.M., Sandri, M., Campodoni, E., Dapporto, M., Sprio, S., Tampieri, A., and Montesi, M. (2020). Scaffold-based 3D cellular models mimicking the heterogeneity of osteosarcoma stem cell niche. Sci. Rep., 10.10.1038/s41598-020-79448-y ↗
59. In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture10.1073/pnas.84.14.5029 ↗
60. The effect of the histoculture drug response assay (HDRA) based perioperative chemotherapy for non-small cell lung cancer
61. Therapeutic response to CDK4/6 inhibition in breast cancer defined by Ex Vivo analyses of human tumors10.4161/cc.21195 ↗
62. A patient-derived explant (PDE) model of hormone-dependent cancer10.1002/1878-0261.12354 ↗
63. Ex Vivo Organ Cultures as Models to Study Bone Biology10.1002/jbm4.10345 ↗
64. Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response10.1016/j.euo.2018.04.019 ↗
65. Advances in osteoclast biology: Old findings and new insights from mouse models10.1038/nrrheum.2011.23 ↗